Up 124% in a year, ASX 300 healthcare share lifts off on $35 million acquisition

ASX investors are bidding up the healthcare share amid ongoing growth.

S&P/ASX 300 Index (ASX: XKO) healthcare share Regis Healthcare Ltd (ASX: REG) is marching higher today.

Shares in the residential aged care provider closed yesterday trading for $5.83. In morning trade on Friday, shares are trading for $5.97 apiece, up 2.4%.

For some context, the ASX 300 is up 0.5% at this same time.

As you can see on the chart above, the Regis Healthcare share price is now up 123.6% over the past 12 months. And that doesn't even factor in the two partly franked dividends the company paid out over the year.

Here's what's moving the ASX 300 healthcare stock today.

healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

ASX 300 healthcare stock expands residential aged care footprint

The Regis Healthcare share price is on the rise after the company announced it has entered into binding agreements to acquire two residential aged care homes from Ti Tree Operations.

The ASX 300 healthcare share will pay a net consideration of $35.5 million to the privately-owned residential aged care provider for the new assets.

The residential aged care homes are located in Capel Sound and Mornington in Victoria. They provide a combined 262 beds under the Village Glen trading name.

According to the release, both fully accredited homes had an average occupancy of 96% in Q4 FY 2024.

Commenting on the expansion that looks to be boosting the ASX 300 healthcare share today, Regis CEO Linda Mellors said, "We are excited to add these quality homes to our portfolio and broaden our footprint in Melbourne."

Mellors continued, "We look forward to welcoming the residents, families, employees and communities to Regis and ensuring a seamless transition of services."

Village Glen managing director Chas Jacobsen added:

We are delighted that Regis will be the new owner and custodian of the Capel Sound and Mornington facilities. We look forward to an ongoing and productive relationship between the parties into the future via our co-located retirement village.

The transaction remains subject to the customary regulatory approvals and conditions.

Regis expects the acquisition to settle on 2 December this year. It will be funded by the company's existing cash.

Once the acquisition is complete, and post the September closure of its Weston home in Western Australia, the ASX 300 healthcare share's aged care portfolio will expand to 68 homes with approximately 7,660 beds.

Atop that, Regis' new 112-bed residential aged care home in Camberwell, Victoria is scheduled to open by late 2024.

Regis comments on healthcare reforms

Separately, the ASX 300 healthcare share also applauded the government's bipartisan historic funding reforms to improve Australia's aged care system.

Commenting on those reforms, Mellors said:

After many years of chronic underfunding with a significant portion of the sector operating at a loss, we are now expecting more predictable and sustainable funding to invest in high-quality services and aged care homes that Australians expect…

As a result, Regis will now commence three greenfield developments in FY 2025, which will add 323 high quality beds to the portfolio.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Happy businessman fist pumping while looking at a tablet.
Healthcare Shares

Mesoblast wins FDA nod for new Ryoncil potency test

Mesoblast gets FDA approval for a new Ryoncil potency assay, aiming to ensure quality and support product expansion.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces.
Healthcare Shares

Can CSL shares hit $200? 3 things that need to go right

CSL needs to prove its earnings engine is accelerating again, not merely stabilising.

Read more »

Group of doctors celebrate by pumping fists in the air.
Healthcare Shares

Telix Pharmaceuticals vs Ramsay Healthcare: Which ASX healthcare stock made investors richer in 2026?

And find out which has the strongest upside ahead.

Read more »

Buy and sell written on red dice on top of stock market charts.
Broker Notes

Up 98%: Are CSL shares now a buy, hold or sell?

A leading expert provides his forecast for CSL’s rocketing shares.

Read more »

Doctor with stethoscope using a tablet in a hospital.
Broker Notes

What is this broker's view on Telix shares after yesterday's crash?

Here is the latest outlook from Bell Potter.

Read more »

Doctor with stethoscope holding a tablet and smiling.
Healthcare Shares

How much could the CSL share price rise in the next year?

Can CSL continue delivering very healthy returns?

Read more »

Male and female scientists analysing data on a computer.
Healthcare Shares

Telix shares just crashed 12% on merger news. Time to buy the dip?

Integration, regulatory milestones and dilution are the real tests now.

Read more »

A female scientist in a laboratory setting using a tablet to review data, with a male scientist working in the background.
Healthcare Shares

Sigma Healthcare vs Sonic Healthcare: Which ASX healthcare share wins?

I compare Sigma Healthcare and Sonic Healthcare to reveal which ASX healthcare share I think is the better buy right…

Read more »